Amgen Announces $650 Million Expansion of U.S. Manufacturing Network

Amgen has announced a $650 million expansion of its U.S. manufacturing network to support increased drug production at the company’s biologics manufacturing facility in Juncos, Puerto Rico, and to integrate innovative advanced technologies throughout the operations process.

The expansion is expected to create nearly 750 jobs, including construction roles and new highly skilled manufacturing jobs.

“This expansion underscores Amgen’s commitment to U.S. biomanufacturing and to strengthening the resilience of our global supply chain,” said Robert A. Bradway, chairman and chief executive officer at Amgen. “By growing our capacity to deliver innovative medicines with cutting-edge technology in our manufacturing plants, we will not only better serve patients but also create high-quality jobs that reinforce America’s leadership in biotechnology.”

This announcement builds on Amgen’s recent investments, including a $600 million science and innovation center in California and manufacturing expansions of $900 million in Ohio and $1 billion in North Carolina, respectively.